Tarsus Pharmaceuticals, Inc. (TARS)
68.20
-3.88
(-5.38%)
USD |
NASDAQ |
Oct 23, 16:00
68.16
-0.04
(-0.06%)
After-Hours: 20:00
Tarsus Pharmaceuticals Price to Book Value : 8.511 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.511 |
| October 22, 2026 | 8.995 |
| October 21, 2026 | 8.798 |
| October 20, 2026 | 8.864 |
| October 19, 2026 | 8.673 |
| October 16, 2026 | 8.495 |
| October 15, 2026 | 8.859 |
| October 14, 2026 | 9.022 |
| October 13, 2026 | 8.838 |
| October 12, 2026 | 9.285 |
| October 09, 2026 | 9.130 |
| October 08, 2026 | 9.013 |
| October 07, 2026 | 9.186 |
| October 06, 2026 | 9.249 |
| October 05, 2026 | 9.292 |
| October 02, 2026 | 9.110 |
| October 01, 2026 | 9.417 |
| September 30, 2026 | 9.810 |
| September 29, 2026 | 9.571 |
| September 28, 2026 | 9.586 |
| September 25, 2026 | 9.446 |
| September 24, 2026 | 9.480 |
| September 23, 2026 | 9.271 |
| September 22, 2026 | 9.619 |
| September 21, 2026 | 9.667 |
| Date | Value |
|---|---|
| September 18, 2026 | 9.745 |
| September 17, 2026 | 9.863 |
| September 16, 2026 | 9.689 |
| September 15, 2026 | 9.763 |
| September 14, 2026 | 9.978 |
| September 11, 2026 | 9.898 |
| September 10, 2026 | 10.12 |
| September 09, 2026 | 10.33 |
| September 08, 2026 | 10.88 |
| September 04, 2026 | 11.33 |
| September 03, 2026 | 10.38 |
| September 02, 2026 | 10.33 |
| September 01, 2026 | 9.241 |
| August 31, 2026 | 9.265 |
| August 28, 2026 | 8.956 |
| August 27, 2026 | 8.975 |
| August 26, 2026 | 8.817 |
| August 25, 2026 | 8.917 |
| August 24, 2026 | 9.086 |
| August 21, 2026 | 9.073 |
| August 20, 2026 | 8.922 |
| August 19, 2026 | 9.165 |
| August 18, 2026 | 8.864 |
| August 17, 2026 | 8.813 |
| August 14, 2026 | 8.636 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bristol Myers Squibb Co. | 5.628 |
| Amneal Pharmaceuticals, Inc. | 197.06 |
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
Price to Book Value Related Metrics
| PS Ratio | 4.829 |
| Price to Free Cash Flow | 52.29 |
| Price | 68.20 |
| Earnings Yield | -1.58% |
| Market Cap | 2.951B |